查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829913

2025年全球定量喷雾吸入器市场报告

Metered Dose Inhaler Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，定量喷雾吸入器市场规模强劲成长，从2024年的154.6亿美元成长到2025年的162.3亿美元，复合年增长率为5.0%。预测期内的成长归因于糖尿病盛行率的上升、定量喷雾吸入器需求的增加、以及定量喷雾吸入器肺病（COPD）盛行率的上升。

预计未来几年定量喷雾吸入器市场规模将强劲成长，到2029年将达到200.3亿美元，复合年增长率为5.4%。预测期内的成长归因于慢性阻塞性肺病盛行率的上升、气喘盛行率的上升、感染疾病病率的上升、糖尿病盛行率的上升以及呼吸系统疾病发生率的上升。预测期内的主要趋势包括技术进步、创新治疗方法、监管部门的核准、新型吸入器创新以及线上行销工具的采用。

定量吸入器 (MDI) 是一种透过吸入将特定剂量的雾化药物直接输送至肺部的医疗设备。这类吸入器广泛用于治疗气喘、慢性阻塞性肺病(COPD) 等呼吸系统疾病以及其他各种肺部疾病。

定量喷雾吸入器吸入器有多种类型，包括桌上型定量吸入器和携带式定量吸入器。桌上型定量喷雾吸入器是主要用于临床的固定式设备，提供可控剂量的雾化药物。这类设备可透过线上和线下通路购买，常用于治疗气喘和慢性阻塞性肺病 (COPD) 等疾病。它们的终端使用者多种多样，包括医院、诊所和家庭护理机构。

2025年春季，美国关税上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供定量喷雾吸入器市场统计数据，包括全球市场规模、区域份额、竞争对手的定量喷雾吸入器市场份额、详细的定量喷雾吸入器市场细分、市场趋势和机会，以及在定量喷雾吸入器行业取得成功所需的数据。这份定量喷雾吸入器定量喷雾吸入器研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年5.4%的预测成长率比我们先前对该市场的预测略有下降，下降了0.1%。下降的主要原因是美国与其他国家之间关税的影响。这种影响将直接影响美国，导致瑞士精密瓣膜供应链中断，可能导致气喘和慢性阻塞性肺病(COPD) 药物供应系统短缺，并影响呼吸系统护理。此外，互惠关税以及贸易紧张局势加剧和限制措施对全球经济和贸易的负面影响也将更广泛地显现。

慢性阻塞性肺病(COPD) 盛行率的不断上升预计将推动定量吸入器 (MDI) 市场的扩张。 COPD 是一种以气流受限为特征的进行进行性肺部疾病，通常由长期接触烟草烟雾等刺激物引起，导致呼吸急促、咳嗽和喘息等症状。 COPD 患者的增加归因于烟草消费、空气污染、人口老化以及诊断和治疗延迟等因素。 MDI 设备对于 COPD 管理至关重要，它可以将药物直接输送到肺部，快速缓解症状并改善气流。例如，美国政府机构国立卫生研究院在 2023 年 12 月预测，COPD 患者数量将从 2030 年的 5.32 亿增加到 2050 年的 5.92 亿。因此，COPD 盛行率的不断上升刺激了对定量喷雾吸入器的需求。

定量喷雾吸入器市场的主要企业正专注于开发先进技术，例如加压计量吸入器 (pMDI)，以提高药物输送效率并改善患者依从性。 pMDI 使用加压推进剂以气雾剂的形式释放特定量的药物。例如，2023 年 7 月，印度製药公司 Lupin Limited 在德国推出了 Luforbec 100/6，这是一种用于治疗成人气喘和慢性阻塞性肺病(COPD) 的 pMDI。此吸入器结合了 100 μg 倍氯米松和 6 μgBudesonide，为患者提供有效的联合治疗。值得注意的是，Luforbec 的价格比固定参考价格低约 47%，更实惠。由于气喘影响德国约 5% 的成年人，此次发布凸显了 Lupin 致力于满足巨大的医疗保健需求和改善呼吸护理结果。

2022年3月，美国工业设备製造商RV Industries, Inc.收购了MBC Aerosol Inc.，收购金额未揭露。此次收购旨在增强RV Industries的气雾剂加工和包装能力，拓展其在宾州以外的业务，支持其收购式成长策略，并确保多个垂直领域的稳定性和效率提升。 MBC Aerosol Inc.是一家专注于生产定量喷雾吸入器(MDI)的美国製造商。

定量喷雾吸入器市场涵盖支气管扩张剂、皮质类固醇、复方吸入器和抗胆碱能药物等产品的销售。此市场的价值是指“出厂价”，即产品製造商或生产者向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品价值。该市场的产品价值还包括产品生产者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球定量喷雾吸入器：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球定量喷雾吸入器市场：增长率分析
  • 全球定量喷雾吸入器市场表现：规模与成长，2019-2024
  • 全球定量喷雾吸入器市场预测：规模与成长，2024-2029年，2034年
  • 全球定量喷雾吸入器：总目标市场（TAM）

第六章 市场细分

  • 全球定量喷雾吸入器市场类型、性能及预测（2019-2024、2024-2029、2034）
  • 桌上型定量喷雾吸入器
  • 可携式定量喷雾吸入器
  • 其他类型
  • 全球定量喷雾吸入器市场（按分销管道）：业绩与预测，2019-2024 年、2024-2029 年、2034 年
  • 在线的
  • 离线
  • 全球定量喷雾吸入器市场的应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 气喘
  • 慢性阻塞性肺病
  • 其他用途
  • 全球定量喷雾吸入器市场（按最终用户、业绩及预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊所
  • 居家照护环境
  • 其他最终用户
  • 全球定量喷雾吸入器市场：桌上型定量吸入器的细分（按类型）、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 标准桌面 MDI 设备
  • 高效能桌面 MDI 设备
  • 智慧桌面 MDI 设备
  • 全球定量喷雾吸入器市场：可携式定量喷雾吸入器细分（按类型）、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 传统可携式MDI 设备
  • 先进的可携式MDI 设备
  • 智慧型可携式MDI设备
  • 全球定量喷雾吸入器市场：按类型、其他、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 基于雾化器的MDI设备
  • 干粉吸入器（DPI）组合装置
  • 缓雾吸入器（SMI）设备
  • 其他特殊 MDI 设备

第七章 区域和国家分析

  • 全球定量喷雾吸入器市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球定量喷雾吸入器市场：国家、绩效及预测，2019-2024、2024-2029、2034

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 定量喷雾吸入器市场：竞争格局
  • 定量喷雾吸入器市场：公司简介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
    • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
    • 3M Company Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Boehringer Ingelheim GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Berry Global Inc.
  • AptarGroup Inc.
  • Philips Healthcare
  • Chiesi Farmaceutici SpA
  • Cipla Limited
  • Gerresheimer AG
  • Zydus Lifesciences Limited
  • Mylan NV
  • Nemera
  • Beximco Pharmaceuticals Limited
  • Cohero Health Inc.
  • Bespak Europe Ltd.
  • Trudell Medical International

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年定量喷雾吸入器市场：提供新机会的国家
  • 2029年定量喷雾吸入器市场：细分市场带来新机会
  • 2029年定量喷雾吸入器市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r33808u

Metered dose inhalers (MDIs) are medical devices that deliver a specific amount of aerosolized medication directly into the lungs through inhalation. These inhalers are widely used to manage respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and various other lung diseases.

There are several types of metered dose inhaler devices, including desktop metered dose inhalers, portable metered dose inhalers, and others. Desktop metered dose inhalers are fixed devices primarily found in clinical environments, providing a controlled dose of aerosolized medication. These devices are available through both online and offline distribution channels and are commonly used for conditions such as asthma and COPD. They serve a range of end users, including hospitals, clinics, homecare settings, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The metered dose inhaler devices market research report is one of a series of new reports from The Business Research Company that provides metered dose inhaler devices market statistics, including metered dose inhaler devices industry global market size, regional shares, competitors with a metered dose inhaler devices market share, detailed metered dose inhaler devices market segments, market trends and opportunities, and any further data you may need to thrive in the metered dose inhaler devices industry. This metered dose inhaler devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The metered dose inhaler devices market size has grown strongly in recent years. It will grow from $15.46 billion in 2024 to $16.23 billion in 2025 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to increased prevalence of diabetes, increased demand for metered dose inhaler devices, increased metered dose inhaler devices, increased demand for metered dose inhaler devices, and increased prevalence of COPD.

The metered dose inhaler devices market size is expected to see strong growth in the next few years. It will grow to $20.03 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to the increasing prevalence of chronic obstructive pulmonary diseases, rising prevalence in asthma, increasing prevalence of infectious diseases, rising prevalence of diabetes, and increasing incidence of respiratory diseases. Major trends in the forecast period include technological advancements, innovative therapies, regulatory approvals, innovations of new inhalers, and adoption of online marketing tools.

The forecast of 5.4% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for precision valves from Switzerland, potentially creating shortages of asthma and chronic obstructive pulmonary disease (COPD) medication delivery systems and impacting respiratory care.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of chronic obstructive pulmonary diseases (COPD) is expected to drive the expansion of the metered dose inhaler (MDI) devices market. COPD is a progressive lung condition marked by airflow restriction, usually caused by prolonged exposure to irritants such as cigarette smoke, and leads to symptoms such as shortness of breath, coughing, and wheezing. The rise in COPD cases can be attributed to factors such as tobacco consumption, air pollution, an aging population, and delayed diagnosis or treatment. MDI devices are vital in managing COPD by delivering medication directly to the lungs, offering rapid relief and improving airflow. For example, in December 2023, the National Institutes of Health, a US-based government agency, projected that COPD cases would increase from 532 million in 2030 to 592 million by 2050. Consequently, the growing prevalence of COPD is fueling the demand for metered dose inhaler devices.

Leading companies in the metered dose inhaler devices market are concentrating on developing advanced technologies, such as pressurized metered dose inhalers (pMDIs), to boost medication delivery efficiency and increase patient adherence. pMDIs are devices that release a specific dose of medication in aerosol form using a pressurized propellant. For example, in July 2023, Lupin Limited, an India-based pharmaceutical company, introduced Luforbec 100/6, a pMDI aimed at treating adult asthma and chronic obstructive pulmonary disease (COPD) in Germany. This inhaler combines 100 µg of beclometasone and 6 µg of formoterol, offering an effective combination therapy for patients. Notably, Luforbec is priced around 47% below the fixed reference price, making it more affordable. Given that approximately 5% of adults in Germany suffer from asthma, this launch highlights Lupin's dedication to meeting significant healthcare demands and improving respiratory care outcomes.

In March 2022, R-V Industries, Inc., a US-based manufacturer of industrial equipment, acquired MBC Aerosol Inc. for an undisclosed sum. This acquisition is intended to strengthen R-V Industries' aerosol processing and packaging capabilities, broaden its operations beyond Pennsylvania, and support its growth strategy through acquisitions, ensuring greater stability and efficiency across multiple industries. MBC Aerosol Inc. is a US-based manufacturer specializing in the production of metered dose inhalers (MDIs).

Major players in the metered dose inhaler devices market are Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, GlaxoSmithKline plc, 3M Company, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Berry Global Inc., AptarGroup Inc., Philips Healthcare, Chiesi Farmaceutici S.p.A., Cipla Limited, Gerresheimer AG, Zydus Lifesciences Limited, Mylan N.V., Nemera, Beximco Pharmaceuticals Limited, Cohero Health Inc., Bespak Europe Ltd., Trudell Medical International, and Iconovo AB.

North America was the largest region in the metered dose inhaler devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in metered dose inhaler devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the metered dose inhaler devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The metered dose inhaler devices market consists of sales of products including bronchodilators, corticosteroids, combination inhalers, and anticholinergics. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Metered Dose Inhaler Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on metered dose inhaler devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for metered dose inhaler devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The metered dose inhaler devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Desktop Metered Dose Inhaler Devices; Portable Metered Dose Inhaler Devices; Other Types
  • 2) By Distribution Channel: Online; Offline
  • 3) By Application: Asthma; Chronic Obstructive Pulmonary Disease; Other Applications
  • 4) By End-User: Hospitals; Clinics; Homecare Settings; Other End Users
  • Subsegments:
  • 1) By Desktop Metered Dose Inhaler Devices: Standard desktop MDI devices; High-performance desktop MDI devices; Smart desktop MDI devices
  • 2) By Portable Metered Dose Inhaler Devices: Conventional portable MDI devices; Advanced portable MDI devices; Smart portable MDI devices
  • 3) By Other Types: Nebulizer-Based MDI devices; Dry powder inhaler (DPI) combined devices; Soft mist inhaler (SMI) devices; Other specialized MDI devices
  • Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AstraZeneca PLC; GlaxoSmithKline plc; 3M Company; Boehringer Ingelheim GmbH; Teva Pharmaceutical Industries Ltd.; Berry Global Inc.; AptarGroup Inc.; Philips Healthcare; Chiesi Farmaceutici S.p.A.; Cipla Limited; Gerresheimer AG; Zydus Lifesciences Limited; Mylan N.V.; Nemera; Beximco Pharmaceuticals Limited; Cohero Health Inc.; Bespak Europe Ltd.; Trudell Medical International; Iconovo AB
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Metered Dose Inhaler Devices Market Characteristics

3. Metered Dose Inhaler Devices Market Trends And Strategies

4. Metered Dose Inhaler Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Metered Dose Inhaler Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Metered Dose Inhaler Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Metered Dose Inhaler Devices Market Growth Rate Analysis
  • 5.4. Global Metered Dose Inhaler Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Metered Dose Inhaler Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Metered Dose Inhaler Devices Total Addressable Market (TAM)

6. Metered Dose Inhaler Devices Market Segmentation

  • 6.1. Global Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Desktop Metered Dose Inhaler Devices
  • Portable Metered Dose Inhaler Devices
  • Other Types
  • 6.2. Global Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Online
  • Offline
  • 6.3. Global Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Other Applications
  • 6.4. Global Metered Dose Inhaler Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Homecare Settings
  • Other End Users
  • 6.5. Global Metered Dose Inhaler Devices Market, Sub-Segmentation Of Desktop Metered Dose Inhaler Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard desktop MDI devices
  • High-performance desktop MDI devices
  • Smart desktop MDI devices
  • 6.6. Global Metered Dose Inhaler Devices Market, Sub-Segmentation Of Portable Metered Dose Inhaler Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Conventional portable MDI devices
  • Advanced portable MDI devices
  • Smart portable MDI devices
  • 6.7. Global Metered Dose Inhaler Devices Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nebulizer-Based MDI devices
  • Dry powder inhaler (DPI) combined devices
  • Soft mist inhaler (SMI) devices
  • Other specialized MDI devices

7. Metered Dose Inhaler Devices Market Regional And Country Analysis

  • 7.1. Global Metered Dose Inhaler Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Metered Dose Inhaler Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Metered Dose Inhaler Devices Market

  • 8.1. Asia-Pacific Metered Dose Inhaler Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Metered Dose Inhaler Devices Market

  • 9.1. China Metered Dose Inhaler Devices Market Overview
  • 9.2. China Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Metered Dose Inhaler Devices Market

  • 10.1. India Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Metered Dose Inhaler Devices Market

  • 11.1. Japan Metered Dose Inhaler Devices Market Overview
  • 11.2. Japan Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Metered Dose Inhaler Devices Market

  • 12.1. Australia Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Metered Dose Inhaler Devices Market

  • 13.1. Indonesia Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Metered Dose Inhaler Devices Market

  • 14.1. South Korea Metered Dose Inhaler Devices Market Overview
  • 14.2. South Korea Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Metered Dose Inhaler Devices Market

  • 15.1. Western Europe Metered Dose Inhaler Devices Market Overview
  • 15.2. Western Europe Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Metered Dose Inhaler Devices Market

  • 16.1. UK Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Metered Dose Inhaler Devices Market

  • 17.1. Germany Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Metered Dose Inhaler Devices Market

  • 18.1. France Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Metered Dose Inhaler Devices Market

  • 19.1. Italy Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Metered Dose Inhaler Devices Market

  • 20.1. Spain Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Metered Dose Inhaler Devices Market

  • 21.1. Eastern Europe Metered Dose Inhaler Devices Market Overview
  • 21.2. Eastern Europe Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Metered Dose Inhaler Devices Market

  • 22.1. Russia Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Metered Dose Inhaler Devices Market

  • 23.1. North America Metered Dose Inhaler Devices Market Overview
  • 23.2. North America Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Metered Dose Inhaler Devices Market

  • 24.1. USA Metered Dose Inhaler Devices Market Overview
  • 24.2. USA Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Metered Dose Inhaler Devices Market

  • 25.1. Canada Metered Dose Inhaler Devices Market Overview
  • 25.2. Canada Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Metered Dose Inhaler Devices Market

  • 26.1. South America Metered Dose Inhaler Devices Market Overview
  • 26.2. South America Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Metered Dose Inhaler Devices Market

  • 27.1. Brazil Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Metered Dose Inhaler Devices Market

  • 28.1. Middle East Metered Dose Inhaler Devices Market Overview
  • 28.2. Middle East Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Metered Dose Inhaler Devices Market

  • 29.1. Africa Metered Dose Inhaler Devices Market Overview
  • 29.2. Africa Metered Dose Inhaler Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Metered Dose Inhaler Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Metered Dose Inhaler Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Metered Dose Inhaler Devices Market Competitive Landscape And Company Profiles

  • 30.1. Metered Dose Inhaler Devices Market Competitive Landscape
  • 30.2. Metered Dose Inhaler Devices Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. 3M Company Overview, Products and Services, Strategy and Financial Analysis

31. Metered Dose Inhaler Devices Market Other Major And Innovative Companies

  • 31.1. Boehringer Ingelheim GmbH
  • 31.2. Teva Pharmaceutical Industries Ltd.
  • 31.3. Berry Global Inc.
  • 31.4. AptarGroup Inc.
  • 31.5. Philips Healthcare
  • 31.6. Chiesi Farmaceutici S.p.A.
  • 31.7. Cipla Limited
  • 31.8. Gerresheimer AG
  • 31.9. Zydus Lifesciences Limited
  • 31.10. Mylan N.V.
  • 31.11. Nemera
  • 31.12. Beximco Pharmaceuticals Limited
  • 31.13. Cohero Health Inc.
  • 31.14. Bespak Europe Ltd.
  • 31.15. Trudell Medical International

32. Global Metered Dose Inhaler Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Metered Dose Inhaler Devices Market

34. Recent Developments In The Metered Dose Inhaler Devices Market

35. Metered Dose Inhaler Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Metered Dose Inhaler Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Metered Dose Inhaler Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Metered Dose Inhaler Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer